Investment Stage

Focus Areas

About Investor

Karthik Ardhanareeswaran is a Partner at GV (formerly Google Ventures), where he focuses on life-sciences and therapeutics investments. His investing profile shows a typical range of $250K to $50.0M, primarily backing seed and Series A biotech, therapeutics and drug-discovery companies, with the capacity to follow on into later stages from GV’s larger funds. He concentrates on platforms and therapeutics emerging from cutting-edge biology, often rooted in academic research, and has led or co-led several GV life-science deals. Before joining GV, Karthik was a Vice President and quantitative researcher at D. E. Shaw & Co., developing algorithmic trading strategies and statistical market models, and earlier worked as a stem-cell and bioinformatics researcher at Yale’s Child Study Center. He completed both his undergraduate and graduate work at Yale University in Molecular, Cellular and Developmental Biology.